INTRODUCTION
- 1 April 2000
- journal article
- Published by Oxford University Press (OUP) in The Oncologist
- Vol. 5 (S1), 1-2
- https://doi.org/10.1634/theoncologist.5-suppl_1-1
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Clinical applications of angiogenic growth factors and their inhibitorsNature Medicine, 1999
- Does vascular endothelial growth factor (VEGF) predict local relapse and survival in radiotherapy-treated node-negative breast cancer?British Journal of Cancer, 1999
- Vascular endothelial growth factor is of high prognostic value in node-negative breast carcinoma.Journal of Clinical Oncology, 1998
- Regulation of VEGF/VPF expression in tumor cells: Consequences for tumor growth and metastasisCancer and Metastasis Reviews, 1996
- Association of vascular endothelial growth factor expression with intratumoral microvessel density and tumour cell proliferation in human epidermoid lung carcinomaBritish Journal of Cancer, 1996
- Enhancement of Tumor Growth and Vascular Density by Transfection of Vascular Endothelial Cell Growth Factor Into MCF-7 Human Breast Carcinoma CellsJNCI Journal of the National Cancer Institute, 1995
- Potentiation of cytotoxic cancer therapies by TNP‐470 alone and with other anti‐angiogenic agentsInternational Journal of Cancer, 1994
- Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutantNature, 1994
- Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivoNature, 1993
- TUMOR DORMANCY IN VIVO BY PREVENTION OF NEOVASCULARIZATIONThe Journal of Experimental Medicine, 1972